Bottom line
What is FACTX's expense ratio?
FACTX's expense ratio is 1.21%, or about $121 a year on every $10,000 invested. That is more expensive than 70% of health care sector funds we track (median 0.96%). Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Sep 24, 2026
FACTX fee table
| Net expense ratio | 1.21% |
|---|---|
| Gross expense ratio | 1.21% |
| Management fee | 0.66% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.05% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Sep 24, 2026
What FACTX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| FACTX | $469 | $721 | $992 | $1,765 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.21% expense ratio costs roughly $65,800 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).